Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties. 

Biotechnology

Ambrx

Sonja Nelson

Sandra Aung

Mike Tattory

Colin Hessel

Jason Schnieder

Lilly Vukov

Renu Vaish

Mingchao Kang

Bridget O'Keeffe

Johanna Acosta

Leadership Team

Regulatory Affairs and Quality Assurance

Clinical Research and Development

Teams at Ambrx

Leadership Team

Regulatory Affairs and Quality Assurance

Clinical Research and Development